Clomid’s Role in Ovulation Induction for PCOS

Clomid, or clomiphene citrate, stimulates the pituitary gland to release more follicle-stimulating hormone (FSH) and luteinizing hormone (LH). This increased hormone production encourages the ovaries to produce and release mature eggs, thereby inducing ovulation in women with PCOS who experience infrequent or absent ovulation.

Doctors typically prescribe Clomid in a cycle starting on days 3-5 of a woman’s menstrual cycle. The dosage is adjusted based on individual response and monitored via ultrasounds to track follicle growth. Treatment usually lasts for 5 days.

Success rates vary depending on factors like age, PCOS severity, and duration of infertility. Studies show ovulation rates improve in roughly 70-80% of women with PCOS taking Clomid. However, pregnancy rates are lower, typically ranging from 20-30% per cycle.

Multiple pregnancies (twins or more) are a potential side effect, occurring in approximately 5-10% of Clomid users. Other common side effects include hot flashes, mood swings, headaches, and visual disturbances. Severe side effects are rare.

Clomid is generally a first-line treatment for ovulation induction in PCOS. If Clomid fails to induce ovulation after several cycles, alternative treatments like letrozole or injectable medications may be considered. Close monitoring by your physician is vital throughout the treatment process.